Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Ventyx Biosciences, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/19/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/11/2023 |
SC 13D/A
| NSV Investments I, L.P. reports a 14.6% stake in ——————— VENTYX BIOSCIENCES, INC. |
| 03/22/2023 |
SC 13D/A
| NSV Investments I, L.P. reports a 20.9% stake in ——————— VENTYX BIOSCIENCES, INC. |
| 03/02/2023 |
SC 13D/A
| NSV Investments I, L.P. reports a 22.9% stake in ——————— VENTYX BIOSCIENCES, INC. |
| 01/30/2023 |
SC 13D/A
| venBio Global Strategic Fund III, L.P. reports a 4.8% stake in Ventyx Biosciences, Inc. |
| 12/30/2022 |
SC 13D/A
| NSV Investments I, L.P. reports a 22.9% stake in ——————— VENTYX BIOSCIENCES, INC. |
| 12/16/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/15/2022 |
SC 13D/A
| venBio Global Strategic Fund III, L.P. reports a 6.1% stake in Ventyx Biosciences, Inc. |
| 11/09/2022 |
SC 13D/A
| Third Point Management reports a 4% stake in Ventyx Biosciences, Inc. |
| 09/20/2022 |
SC 13D/A
| NSV Investments I, L.P. reports a 30% stake in Ventyx Biosciences, Inc. |
| 09/14/2022 |
SC 13D/A
| venBio Global Strategic Fund III, L.P. reports a 10% stake in Ventyx Biosciences, Inc. |
|
|